Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Bristol Myers to build ‘powerful’ AI factory; Samsung Biologics bids for peptide maker
1+ day, 6+ hour ago (150+ words) Bristol Myers is the third pharmaceutical company to recently seek Nvidia’s help building a large AI data center. Elsewhere, a Novartis kidney drug gained a leg up on competitors. Today, a brief rundown of news involving Bristol Myers Squibb and…...
Bristol Myers deepens AI investment with Anthropic deal
2+ mon, 16+ hour ago (365+ words) The collaboration marks an “evolution” in the pharmaceutical giant’s use of AI and adds to a series of broad deals its peers have used to adopt the technology across many day-to-day activities. Bristol Myers is the latest drugmaker to make…...
After finding ‘irregularities,’ Bristol Myers to extend key trial of Cobenfy in Alzheimer’s psychosis
7+ mon, 2+ week ago (502+ words) Data from the “ADEPT-2” study, which analysts had hoped would arrive before year’s end, are now expected sometime in 2026. Data from a closely watched study evaluating Bristol Myers Squibb’s mind-stabilizing medicine Cobenfy in patients with Alzheimer’s disease could now come…...
Bristol Myers, J&J’s new blood thinner fails first big test
8+ mon, 6+ day ago (297+ words) Milvexian’s failure in acute coronary syndrome dampens the outlook for other anticoagulants like it and is the latest in a series of clinical setbacks this year for Bristol Myers. Bristol Myers and J&J are in the middle of an…...
Bristol Myers shuffles its executive ranks with new CMO
11+ mon, 3+ week ago (451+ words) Cristian Massacesi, who has been AstraZeneca’s chief medical officer and cancer research head, will join the company on Aug. 1. AstraZeneca executive Cristian Massacesi will join Bristol Myers Squibb as its chief medical officer, replacing outgoing executive Samit Hirawat, the company…...